Rosty Raykov, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 10,000 shares at $7.54 ($75K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Scheduled sale ($75k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FENC | SELL | 2026-07-02 | $100K | — | Filing → |
| FENC | SELL | 2026-06-02 | $94K | — | Filing → |
| FENC | SELL | 2026-05-01 | $70K | — | Filing → |